Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Neoplasms 8Colorectal Neoplasms 7Prostatic Neoplasms 6Stomach Neoplasms 5Lung Neoplasms 5Breast Neoplasms 5Endometrial Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Sarcoma 3Pancreatic Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Oropharyngeal Neoplasms 2Obesity 2Meningioma 2Melanoma 2Lymphoma, Large B-Cell, Diffuse 2Esophageal Neoplasms 2Disease 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Carcinoma, Basal Cell 2Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Surgical Wound Dehiscence 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Small Cell Lung Carcinoma 1Skull Base Neoplasms 1Skin Neoplasms 1Salivary Gland Neoplasms 1

Interventions

fluorodopa F 18 2Observation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Insulinoma × Observation × Clear all
NCT07272187 2025-12-09

EURAGIL

Herlev Hospital

Recruiting
138 enrolled
Endocrine

Hyperaldosteronism, Insulinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡